The benefits and risks associated with breast screening are currently a topic of great academic and public interest. Despite this, relatively little is known about the impact of information on the risks associated with breast screening, particularly information on overdiagnosis.
Are women aware of the issue of overdiagnosis? How can we best communicate overdiagnosis information? And, importantly, what impact might this have on women’s decisions about whether or not to attend breast cancer screening? This article provides an overview of our research, in which we used qualitative methods to explore women’s responses to information on overdiagnosis in breast cancer screening.
By Dr Kelly Winstanley, Dr Katrina Whitaker and Dr Jo Waller. Read More